Autoantibodies and Severity of COVID-19 in Lung Transplant Recipients

PURPOSE: COVID-19 in lung transplant recipients (LTR) results in case-fatality rate of 10-46%. Disease severity is variable and it is unclear why certain groups of patients develop severe disease. Recent report suggests that 10% of patients with life threatening COVID-19 have auto-antibodies (AAbs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaza, V., Mahan, L., Banga, A., Mohanka, M., Bollineni, S., Lawrence, A., Joerns, J., Torres, F., Timofte, I., Lacelle, C., La Hoz, R., Galli, J., Kozlitina, J., Zhu, C., Li, Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
(292)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988551/
http://dx.doi.org/10.1016/j.healun.2022.01.313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988551/
http://dx.doi.org/10.1016/j.healun.2022.01.313

Ejemplares similares